Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis
<p>Abstract</p> <p>Background</p> <p>The secretory leukocyte protease inhibitor (SLPI) exerts wide ranging effects on inflammatory pathways and is upregulated in EAE but the biological role of SLPI in EAE, an animal model of multiple sclerosis is unknown</p> <p...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-03-01
|
| Series: | BMC Neuroscience |
| Subjects: | |
| Online Access: | http://www.biomedcentral.com/1471-2202/13/30 |